Overburden of rare ALMS1 deleterious variants in Chinese early-onset type 2 diabetes with severe insulin resistance

被引:2
|
作者
Zhang, Simin [1 ]
Gong, Siqian [1 ]
Li, Meng [1 ]
Cai, Xiaoling [1 ]
Liu, Wei [1 ]
Lou, Yingying [1 ]
Ma, Yumin [1 ]
Zhang, Xiuying [1 ]
Ren, Qian [1 ]
Zhu, Yu [1 ]
Wu, Jing [1 ]
Zhou, Lingli [1 ]
Li, Yufeng [2 ]
Zhou, Xianghai [1 ]
Han, Xueyao [1 ]
Ji, Linong [1 ]
机构
[1] Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Friendship Hosp, Dept Endocrinol, Pinggu Campus, Beijing, Peoples R China
关键词
Alstrom syndrome; early onset diabetes; insulin resistance; next generation sequencing; type; 2; diabetes; ALSTROM-SYNDROME; ASSOCIATION; SPECTRUM; GENE;
D O I
10.1002/dmrr.3788
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Alstrom syndrome (AS) is a rare recessive disorder characterised by diabetes, obesity, insulin resistance (IR), and visual and hearing impairments. Mutations in the ALMS1 gene have been identified as the causative agents of AS. This study aimed to explore the relationship between rare ALMS1 variants and clinical features in Chinese patients with early-onset type 2 diabetes (age at diagnos is <= 40 years; EOD). Materials and Methods: ALMS1 gene sequencing was performed in 611 Chinese individuals with EOD, 36 with postprandial hyperinsulinemia, and 47 with pre-diabetes and fasting IR. In-silico prediction algorithm and the American College of Medical Genetics Guidelines (ACMG) were used to evaluate the deleteriousness and pathogenicity of the variants. Results: Sixty-two rare ALMS1 variants (frequency <0.005) were identified in 82 patients with EOD. Nineteen variants were predicted to be deleterious (pD). Patients with EOD carrying pD variants had higher fasting C-peptide, postprandial C-peptide, and HOMA2-IR levels than those without variants. The frequency of ALMS1 pD variants in the subgroup with more insulin-resistant EOD was higher than that in other EOD subgroups. Two patients with EOD, obesity, and IR who carried one heterozygous pathogenic/likely pathogenic rare variant of ALMS1 according to ACMG were identified. Moreover, rare heterozygous pD variants of ALMS1 were found in participants from cohorts of postprandial hyperinsulinemia as well as in pre-diabetes with fasting IR. Conclusions: ALMS1 rare pD variants are enriched in the populations with significant IR, which is a major hallmark of diabetes pathogenesis. Accordingly, our exploratory study provides insights and hypotheses for further studies of gene function.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] ALMS1 truncation mutations identified by exome sequencing in 11 Chinese families with early-onset severe retinal degeneration
    Xu, Yan
    Guan, Liping
    Xiao, Xueshan
    Zhang, Jianguo
    Li, Shiqiang
    Jiang, Hui
    Jia, Xiaoyun
    Yin, Ye
    Guo, Xiangming
    Zhang, Qingjiong
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [2] PCLO variants are associated with early-onset type 2 diabetes and insulin resistance in pima Indians
    Ma, Lijun
    Hanson, Robert
    Que, Lorem
    Guo, Yan
    Kobes, Sayuko
    Knowler, William
    Bogardus, Clifton
    Baier, Leslie
    DIABETES, 2007, 56 : A19 - A19
  • [3] Contribution of rare and common genetic variants to early-onset type 2 diabetes
    Pezzilli, S.
    Tohidirad, M.
    Biagini, T.
    Alberico, F.
    Mercuri, L.
    Scarale, M. G.
    Garofolo, M.
    Mannino, G. C.
    Filardi, T.
    Andreozzi, F.
    Mazza, T.
    Prudente, S.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S170 - S170
  • [4] PCLO Variants Are Nominally Associated With Early-Onset Type 2 Diabetes and Insulin Resistance in Pima Indians
    Ma, Lijun
    Hanson, Robert L.
    Que, Lorem N.
    Guo, Yan
    Kobes, Sayuko
    Bogardus, Clifton
    Baier, Leslie J.
    DIABETES, 2008, 57 (11) : 3156 - 3160
  • [5] Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes
    Pezzilli, Serena
    Tohidirad, Manoush
    Biagini, Tommaso
    Scarale, Maria Giovanna
    Alberico, Federica
    Mercuri, Luana
    Mannino, Gaia Chiara
    Garofolo, Monia
    Filardi, Tiziana
    Tang, Yaling
    Giuffrida, Fernando
    Mendonca, Christine
    Andreozzi, Francesco
    Baroni, Marco Giorgio
    Buzzetti, Raffaella
    Cavallo, Maria Gisella
    Cossu, Efisio
    D'Angelo, Paola
    De Cosmon, Salvatore
    Lamacchia, Olga
    Leonetti, Frida
    Morano, Susanna
    Morviducci, Lelio
    Penno, Giuseppe
    Pozzilli, Paolo
    Pugliese, Giuseppe
    Sesti, Giorgio
    Mazza, Tommaso
    Doria, Alessandro
    Trischitta, Vincenzo
    Prudente, Sabrina
    DIABETES & METABOLISM, 2022, 48 (05)
  • [6] Lack of association between gene variants in the ALMS1 gene and Type 2 diabetes mellitus
    L. M. 't Hart
    J. M. Dekker
    R. J. Heine
    J. A. Maassen
    Diabetologia, 2003, 46 : 1023 - 1024
  • [7] Lack of association between gene variants in the ALMS1 gene and Type 2 diabetes mellitus
    't Hart, LM
    Maassen, JA
    Dekker, JM
    Heine, RJ
    Maassen, JA
    DIABETOLOGIA, 2003, 46 (07) : 1023 - 1024
  • [8] ALMS1 null mutations: a common cause of Leber congenital amaurosis and early-onset severe cone-rod dystrophy
    Xu, Y.
    Guan, L.
    Xiao, X.
    Zhang, J.
    Li, S.
    Jiang, H.
    Jia, X.
    Yin, Y.
    Guo, X.
    Wang, J.
    Zhang, Q.
    CLINICAL GENETICS, 2016, 89 (04) : 442 - 447
  • [9] Rare Antagonistic Leptin Variants and Severe, Early-Onset Obesity
    Funcke, Jan-Bernd
    Moepps, Barbara
    Roos, Julian
    von Schnurbein, Julia
    Verstraete, Kenneth
    Froehlich-Reiterer, Elke
    Kohlsdorf, Katja
    Nunziata, Adriana
    Brandt, Stephanie
    Tsirigotaki, Alexandra
    Dansercoer, Ann
    Suppan, Elisabeth
    Haris, Basma
    Debatin, Klaus-Michael
    Savvides, Savvas N.
    Farooqi, I. Sadaf
    Hussain, Khalid
    Gierschik, Peter
    Fischer-Posovszky, Pamela
    Wabitsch, Martin
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (24): : 2253 - 2261
  • [10] Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes
    Hearn, T
    Spalluto, C
    Phillips, VJ
    Renforth, GL
    Copin, N
    Hanley, NA
    Wilson, DI
    DIABETES, 2005, 54 (05) : 1581 - 1587